Back to Authors

Nowakowski, Grzegorz S.

https://orcid.org/0000-0002-6955-9393

Mayo Clinic

Mayo Clinic

Citations 513

Frontmind: A Phase III, Multicenter, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma
Nowakowski, Grzegorz S. , Burke, John M. , Waldron-Lynch, Maeve, Wagner, Steve, Pachori, Alok, Lenz, Georg , Vitolo, Umberto , Fox, Christopher P. , Trněný, Marek , Chiappella, Annalisa

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6618-6620

10.1182/blood-2022-155995 Get It

CD19 Antigen Occupancy on Cancer Cells with the CD19 Monoclonal Antibody Tafasitamab Improves the Activation, Antitumor Efficacy, and Safety Profile of CART19 Cell Therapy
Manriquez-Roman, Claudia, Horvei, Paulina , Huynh, Truc, Girsch, James H. , Sirpilla, Olivia , Yun, Kun , Stewart, Carli M. , Ogbodo, Ekene J. , Fonkoua, Lionel Aurelien Kankeu , Ruff, Michael W. , Ilieva-Babinsky, Kristina, Patra-Kneuer, Maria , Heitmüller, Christina, Ding, Wei , Nowakowski, Grzegorz S. , Sakemura, Reona , Cox, Michelle J. , Huynh, Truc , Stewart, Carli , Can, İsmail , Adada, Mohamad M , Hefazi, Mehrdad , Augsberger, Christian , Steidl, Stefan, Parikh, Sameer A. , Kay, Neil E. , Siegler, Elizabeth L. , Kenderian, Saad S.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2362-2364

10.1182/blood-2022-158273 Get It

Five-Year Results and Overall Survival Update from the Phase 3 Randomized Study Augment: Lenalidomide Plus Rituximab (R2) Vs Rituximab Plus Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Leonard, John P. , Offner, Fritz , Mayer, Jiří , Zhang, Huilai , Nowakowski, Grzegorz S. , Gkasiamis, Argyrios, Mikita-Geoffroy, Joanna, Rowe, Everton, Trněný, Marek , Scheinberg, Phillip , Gkasiamis, Argyrios, Gribben, John G.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 561-563

10.1182/blood-2022-158631 Get It

Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World
Nowakowski, Grzegorz S. , Dabas, Rosy , Amoloja, Theresa , Xue, Zhenyi, Koch, Caroline, Waltl, Eva E., Fleury, Isabelle , Peters, Anthea

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3811-3813

10.1182/blood-2022-158550 Get It

Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study
Thiéblemont, Catherine , Visco, Carlo , Gastinne, Thomas , Bouabdallah, Kamal , Nowakowski, Grzegorz S. , Roulin, Louise , Topp, Max S. , Jauhari, Shekeab , Vučinić, Vladan , Martin, Peter , Gkasiamis, Argyrios, Drew, James, Rao, Parth, Cheng, Yiming , Muñoz, Javier , Tucci, Alessandra , Cartron, Guillaume , Corradini, Paolo , Flinn, Ian W. , Arcaini, Luca , Kaplan, Mark H. , Li, Ju, Morschhauser, Franck

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 569-572

10.1182/blood-2022-162559 Get It